
- Volume 0 0
Controlled-Release Paxil Is Effective and Well Tolerated for Social Anxiety Disorder
A multicenter, randomized, double-blind, flexible-dose study showed that 3 times as many patients with social anxiety disorder achieved remission while taking Paxil CR, compared with those taking placebo. The study, published in the Journal of Clinical Psychiatry, also showed that patients had a significantly reduced score on the Liebowitz Social Anxiety Scale, as well as on Fear or Anxiety and Avoidance subscales. Paxil CR is the first and only controlled-release selective serotonin reuptake inhibitor indicated for social anxiety disorder, the most common type of anxiety disorder. Paxil CR also is indicated for treating depression, panic disorder, and premenstrual dysphoric disorder.
Articles in this issue
about 22 years ago
Aging Brings Changesabout 22 years ago
RxPRODUCT NEWS PROFILE: Cubicinabout 22 years ago
Can You Read These Rxs?about 22 years ago
Treatment of Sexually Transmitted Diseasesabout 22 years ago
Pharmacist Misappropriates Trade Secretsabout 22 years ago
Topiramate May Reduce Frequency and Severity of Migraine Headachesabout 22 years ago
HRT Is Linked to Breast Cancer Relapseabout 22 years ago
Early Treatment with Rasagiline May Slow Parkinson's Disease Impairmentabout 22 years ago
Psoriasis May Be Treated Safely and Effectively with Adalimumababout 22 years ago
Small Study Offers Hope for Lung Cancer PatientsNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.



































































































































